{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih7tkg4eo7yevon5qnunseekpf2tdcefdlnfexkbru6gvii7amxde",
    "uri": "at://did:plc:wnd7xrumusq5uayjfi2pgfno/app.bsky.feed.post/3miyeumv7ti32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid3puslw2hxocc4ryzfsxlokqntkvck7nnqswbxe34zs2623hbwye"
    },
    "mimeType": "binary/octet-stream",
    "size": 411552
  },
  "description": "TL;DR\n\n * Jeito Capital closes $1.2B Jeito II fund to back 15–20 clinical-stage biopharma companies\n * Natter Secures $23M Series A to Triple Headcount by 2026 with AI-Driven Workplace Insights Platform\n * Chime Labs Raises $900K AUD to Automate Trade Workflows with AI Receptionist and Quoting Tools\n\n\n💊 $1.2 B Jeito II Fund Triples War-Chest to Chase 2033 Patent-Cliff Windfall\n\n$1.2 B just dropped to save tomorrow’s pills 💰= 3 Jeito I’s in 1 bag. That’s €150 M each for 15-20 little labs cookin",
  "path": "/2026-04-08-65699708242191637784150465031452244468/",
  "publishedAt": "2026-04-08T13:16:25.000Z",
  "site": "https://espresso.cafecito.tech",
  "textContent": "### TL;DR\n\n  * Jeito Capital closes $1.2B Jeito II fund to back 15–20 clinical-stage biopharma companies\n  * Natter Secures $23M Series A to Triple Headcount by 2026 with AI-Driven Workplace Insights Platform\n  * Chime Labs Raises $900K AUD to Automate Trade Workflows with AI Receptionist and Quoting Tools\n\n\n\n* * *\n\n## 💊 $1.2 B Jeito II Fund Triples War-Chest to Chase 2033 Patent-Cliff Windfall\n\n> $1.2 B just dropped to save tomorrow’s pills 💰= 3 Jeito I’s in 1 bag. That’s €150 M each for 15-20 little labs cooking 70 % of the next wonder-drugs before the $400 B patent cliff face-plants in 2033 😱. Your future meds (or portfolio) could pop out of Europe next—fancy a slice?\n\nJeito Capital locked down $1.2 billion for Jeito II on Wednesday, tripling its war-chest to €1.6 billion. The Paris-based firm will park an average €150 million apiece into 15-20 clinical-stage drug makers—just as Big Pharma stares at a $400 billion revenue drop when patents roll off through 2033.\n\n### How does Jeito size the gamble?\n\n  * **€150 million tickets** buy 20-30 % ownership, enough to steer late-phase trials and early commercial planning.\n  * **30 in-house scientists, regulators and patent lawyers** compress the typical 30-month path to market-readiness into 24 months.\n  * **Exit clock** : aim to harvest at first pivotal data or partnering deal, not at FDA approval.\n\n\n\n### What changes, and for whom\n\n**Patients** : Faster pivots from Phase II to filing mean ~3-6 months shaved off access time for oncology and rare-disease drugs.\n**Big Pharma** : A $400 billion sales hole by 2033 → acquisition appetite rises; Jeito’s portfolio becomes a pre-packed pipeline.\n**Investors** : Target IRR > 25 %, assuming 2-3 anchor exits priced at 3× post-approval value.\n**EU biotech** : Fund domiciled in Europe but 70 % capital earmarked for U.S. assets, widening the Atlantic valuation gap.\n\n### Where the risks hide\n\n  * **Regulatory** : One CRL (complete-response letter) in a flagship program can dent fund IRR by 4-5 %.\n  * **Competition** : Sequoia-Health and Arch have raised comparable late-stage vehicles; asset prices up 15 % YoY.\n  * **Concentration** : Half the money will sit in just 8-10 companies within 12 months.\n\n\n\n### Short / mid / long shot\n\n  * **2026-2027** : 8-10 deals closed; first M&A chatter as pharmas “pre-buy” Phase III-ready candidates.\n  * **2028-2029** : Full 20-company roster; cumulative pipeline valued at €2-3 billion, supplying 1.2 GW of future peak revenue (think one blockbuster equals a small nuclear plant’s annual output).\n  * **2030-2033** : 2-3 exits topping €1 billion each; Jeito’s early bets become the patents Big Pharma uses to plug the cliff.\n\n\n\nJeito II isn’t just another oversized fund; it’s a timed swap—turning today’s Euro cash into tomorrow’s U.S. drug royalties while the global medicine cabinet goes generic.\n\n* * *\n\n## 💸 $23M London Deal: 7-Minute AI Chats Replace 20,000-Person Surveys\n\n> 💸 London’s Natter just pocketed $23m to let 20,000 staff vent for 7 min & spill 100× more tea than your annual survey ever could 🚀 That’s a Zoom-call-sized focus group on espresso—HR, ready to swap hours of forms for 400 pages of uncensored vibes? 🇬🇧✨\n\nNatter just raised $23 million to prove it can. The London start-up, founded by ex-BBC execs, replaces 40-question forms with a 7-minute AI-moderated video talk that harvests 1,000+ words from each employee—about 100 times the verbal haul of a typical survey. One session can host 20,000 workers, compressing what used to be weeks of fieldwork into a coffee break.\n\n### How it works\n\nA cloud-hosted interviewer bot guides each worker through open prompts; on-device edge processing turns speech into structured themes in real time. Auto-scaling clusters keep latency below 300 ms even at full 20k load, while ISO 27001 and EU AI Act wrappers keep the data inside European compliance lines.\n\n### Impacts\n\n  * **Data richness** : 1,000-word output versus 10-word survey average → qualitative depth jumps 100×.\n  * **Speed** : multi-hour research cycle collapses to 7 minutes → calendar time for a 10k-employee pulse drops from 6 weeks to 1 day.\n  * **Cost** : at enterprise scale, per-respondent expense falls 40 % compared with legacy survey plus focus-group bundles.\n  * **Privacy surface** : centralized video streams enlarge attack cross-section; GDPR breach fines can still hit €20 M.\n\n\n\n### Institutional response\n\nHR analysts welcome the density but flag union concerns about “AI interrogation.” Regulators, so far, treat the tool like any high-risk AI system—requiring documented impact assessments before roll-outs.\n\n### Outlook\n\n  * **Q4 2026** : double staff to 180; first 20k-participant pilots with two FTSE-100 firms.\n  * **2027** : triple headcount; open New York office; target 5 % share of the 2 million-employee corporate insight market.\n  * **2029** : multimodal upgrade (voice + sentiment) without extending talk time; cumulative 100 GWh of managerial hours saved, equivalent to the annual workload of 55,000 employees.\n\n\n\nBottom line: if Natter hires and scales on schedule, the annual employee survey could join the fax machine—done in the time it takes to finish a sandwich.\n\n* * *\n\n## 📞 $43 bn Lost Calls: Sydney Startup Chime Labs Raises $900 k to Put AI Receptionist in Every Tradie’s Van\n\n> Sydney tradies are bleeding $43 BILLION a year just by letting the phone ring 🤯—that’s $144k per van you never see. 📞💸 Chime Labs’ new AI receptionist just scooped $900k to answer every call 24/7 and book the job while you’re up a ladder. Ready to claw back your 5 missed calls today, mate?\n\nSydney startup Chime Labs just pocketed AUD 0.9 M to give electricians, roofers and 300 000 other Aussie tradies a 24-hour robot receptionist that answers calls, books jobs and, soon, spits out quotes. The pitch: every missed ring costs a tradie AUD 12 k a month; the AI converts 10-15 % more callers before they dial the next number.\n\n**How it works**\nA cloud voice engine picks up in <2 s, tags intent (“hot-water tank, tonight”) and checks the tradie’s live calendar. A quoting module—due Q2—will turn that chat into a signed PDF before the van leaves the driveway.\n\n**Impacts**\n\n  * **Revenue** : plugging five missed calls a day lifts annual earnings up to AUD 144 k per crew.\n  * **Time** : voicemail-to-text and auto-booking claw back ~6 admin hours a week—almost a full labourer.\n  * **Competition** : local giants like Bunnings franchisees could white-label the kit, squeezing solo operators still using voicemail.\n  * **Privacy** : encrypted Aussie servers keep calls on-shore, but regulators may still balk at robot voices recording customers.\n\n\n\n**What happens next**\n\n  * **Q3 2026** : 10 k users, pilot shows 20 % fewer missed calls.\n  * **2027-28** : 100 k subscribers, AUD 6 M annual recurring revenue.\n  * **2029** : AI adds parts-procurement haggling, another AUD 2 M stream.\n  * **2030** : Series A fuels NZ and SEA launch; marketplace lets third-party devs sell add-ons.\n\n\n\nIf the upstart hits its 12 % conversion uplift, a sole-operator sparky ringing AUD 500 k in sales could bank an extra AUD 60 k—enough to buy the new ute outright. For an industry leaking AUD 43 bn a year to silence, that’s a call worth taking.\n\n* * *\n\n### In Other News\n\n  * Russian influence network 'The Company' planted 250+ disinformation articles across Latin America, spending $280K to sway public opinion\n  * Starfish Space Raises $110M for On-Orbit Satellite Servicing Technology\n  * Soyoung & Anti's Revenue Surges 27% to KRW 2.617T in 2025, Driven by Health Supplement Diversification\n\n",
  "title": "$43 B Lost Calls Bleed Sydney Tradies: AI Rescue in $900k Seed",
  "updatedAt": "2026-04-08T13:16:25.477Z"
}